alphaveINDSWFTLAB₹379.00

Ind-Swift Laboratories Limited

₹ CrorePeersSMSPHARMA SOLARA DCAL HIKAL UNICHEMLAB GUFICBIO PANACEABIO RPGLIFEMcap ₹3,291 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	5.4	260.1	275.1	275.1
+ Capital Work-in-Progress	—	—	10.2	10.2
+ Investment Property	2.3	2.3	2.2	2.2
+ Other Intangibles	0.0	10.7	25.2	25.2
+ Intangibles under Development	—	—	2.2	2.2
+ Non-current Investments	110.5	174.1	235.6	235.6
+ Long-term Loans	0.0	73.5	73.5	73.5
+ Other Non-current Financial Assets	0.5	2.1	2.7	2.7
Non-current Financial Assets	111.0	249.7	311.9	311.9
+ Deferred Tax Assets	31.9	44.6	50.3	50.3
+ Other Non-current Assets	353.4	5.6	19.4	19.4
Total Non-current Assets	504.0	573.0	696.6	696.6
Current Assets
+ Inventories	10.5	114.2	147.9	147.9
+ Current Investments	0.0	39.4	11.9	11.9
+ Trade Receivables	169.1	164.5	198.5	198.5
+ Cash & Cash Equivalents	431.9	428.0	429.8	429.8
+ Other Current Financial Assets	—	14.2	30.1	30.1
Current Financial Assets	601.0	646.2	670.4	670.4
+ Other Current Assets	49.6	105.0	158.4	158.4
Total Current Assets	661.1	865.3	976.8	976.8
Total Assets	1,165.1	1,438.3	1,673.3	1,673.3
Equity
+ Equity Share Capital	59.1	68.7	86.8	86.8
+ Other Equity / Reserves	872.4	1,104.3	1,297.2	1,297.2
Equity — Owners of Parent	931.5	1,173.0	1,384.0	1,384.0
+ Minority Interest	-0.0	-0.0	-0.1	-0.1
Total Equity	931.4	1,173.0	1,384.0	1,384.0
Liabilities
+ Borrowings — Non-current	11.2	25.7	12.3	12.3
+ Other Non-current Financial Liab	—	0.2	2.6	2.6
Non-current Financial Liabilities	11.2	25.9	14.9	14.9
+ Provisions — Non-current	1.2	11.4	13.1	13.1
+ Other Non-current Liabilities	—	7.5	6.7	6.7
Non-current Liabilities	12.4	44.8	34.7	34.7
+ Borrowings — Current	5.5	14.9	5.6	5.6
+ Trade Payables	94.0	110.2	145.9	145.9
+ Other Current Financial Liab	—	0.0	0.0	0.0
Current Financial Liabilities	99.4	125.2	151.5	151.5
+ Provisions — Current	101.8	1.8	2.8	2.8
+ Current Tax Liabilities	—	4.2	0.1	0.1
+ Other Current Liabilities	20.1	89.4	100.4	100.4
Current Liabilities	221.3	220.6	254.7	254.7
Total Liabilities	233.7	265.4	289.4	289.4
Total Equity & Liabilities	1,165.1	1,438.3	1,673.3	1,673.3
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	5.9	9.8	9.8
+ Dues to Other Creditors — Current	—	104.4	136.1	136.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.